CureVac N.V. CVAC
Set alert
4.66 USD 0.00 0.00%
At close · Jan 6
4.62 -0.04 -0.86%
After hours · Jan 6, 4:00 PM ET
4.57 Day range 4.66
4.00 52-week range 5.55
- YTD
- +3.10%
- 1 year
- +28.73%
- Open
- 4.57
- Prev close
- 4.66
- Mkt cap
- 1.05B
- Vol
- 728.78K
- Avg vol
- 1.76M
- EPS
- 0.72
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 4.57
- High
- 4.66
- Beta
- 1.84
- Inst. own
- 10.42%
- Dividend
- 0.00
3M chart
Events in this range
- Nov 24, 2025Earnings: -0.1; estimate -0.17; surprise 41.18%
Signals (16)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Dec 31, 2025 | 10 months ago |
| RSI: Oversold | Dec 17, 2025 | 10 months ago |
| MACD: Sell Signal | Dec 3, 2025 | 11 months ago |
| SMA: Bearish | Dec 1, 2025 | 11 months ago |
| SMA: Bearish | Dec 1, 2025 | 11 months ago |
| SMA: Bullish | Nov 26, 2025 | 11 months ago |
| SMA: Bullish | Nov 26, 2025 | 11 months ago |
| MACD: Buy Signal | Nov 26, 2025 | 11 months ago |
| RSI: Oversold | Nov 20, 2025 | 11 months ago |
| RSI: Oversold | Nov 6, 2025 | 12 months ago |
| SMA: Bullish | Oct 22, 2025 | 1 year ago |
| SMA: Bearish | Oct 16, 2025 | 1 year ago |
| SMA: Bullish | Oct 15, 2025 | 1 year ago |
| SMA: Bearish | Oct 14, 2025 | 1 year ago |
| MACD: Sell Signal | Oct 14, 2025 | 1 year ago |
| SMA: Bearish | Oct 10, 2025 | 1 year ago |
Analyst view
Price target (mean) —
Ratings (0m) 4 1 buy · 3 hold · 0 sell
- Strong buy0
- Buy1
- Hold3
- Sell0
- Strong sell0
Recommendation trend
- This month 4
- 1 month ago 5
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.09 | -0.11 – -0.07 | -0.14 | +35.7% | 13.35M | -7.9% | 2 |
| Current year | -0.54162 | -0.71 – -0.25647 | 0.72 | -175.2% | 62.79M | -88.3% | 4 |
| Next year | -0.49676 | -0.73 – -0.26 | -0.54162 | +8.3% | 88.19M | +40.5% | 4 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jun 26, 2025 | UBS | Downgrade | Buy | Neutral |
| Jun 13, 2025 | Jefferies | Downgrade | Buy | Hold |
| May 28, 2025 | JMP Securities | Reiterated | Market Outperform | Market Outperform |
| Apr 30, 2025 | UBS | Maintained | Buy | Buy |
| Feb 14, 2025 | JMP Securities | Reiterated | Market Outperform | Market Outperform |
| Sep 16, 2024 | JMP Securities | Reiterated | Market Outperform | Market Outperform |
| Aug 16, 2024 | JMP Securities | Maintained | Market Outperform | Market Outperform |
| Jul 3, 2024 | JMP Securities | Reiterated | Market Outperform | Market Outperform |
| Apr 25, 2024 | Leerink Partners | Downgrade | Outperform | Market Perform |
| Apr 5, 2024 | Guggenheim | Reiterated | — | Neutral |
| Apr 26, 2021 | Guggenheim | Initiated | — | Buy |
| Dec 10, 2020 | Credit Suisse | Downgrade | Neutral | Underperform |
| Sep 8, 2020 | B of A Securities | Initiated | — | Buy |
| Sep 8, 2020 | Jefferies | Initiated | — | Hold |
| Sep 8, 2020 | Credit Suisse | Initiated | — | Neutral |